Dixon Technologies Nears Vivo Deal, Faces Margin Pressure

INDUSTRIAL-GOODSSERVICES
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Dixon Technologies Nears Vivo Deal, Faces Margin Pressure
Overview

Nuvama Securities recommends 'Buy' on Dixon Technologies, setting a ₹11,700 target price. The company is expected to grow strongly long-term, boosted by mobile manufacturing, an upcoming Vivo joint venture, and expansion into new electronics areas. However, Nuvama cut FY27 earnings forecasts by 6-8% due to expected lower profit margins from higher component costs and weaker consumer demand. Dixon operates in electronics manufacturing, supported by government schemes, but faces price increases and possible delays for key growth projects.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Growth Prospects Amidst Challenges

Nuvama Securities rates Dixon Technologies a 'Buy' with a ₹11,700 target price, seeing potential for 15% upside. The brokerage forecasts strong compound annual growth of 32% in revenue and 27% in EBITDA from FY26 to FY29, driven by mobile manufacturing and expansion into new electronics areas. However, Nuvama has lowered its FY27 earnings per share (EPS) estimates due to concerns about profit margins and near-term demand. The market is closely watching the progress of the Vivo joint venture, which is expected to substantially increase manufacturing volumes.

Key Growth Drivers: Vivo Deal and Diversification

The joint venture with Vivo is a key growth driver for Dixon Technologies. Management reports they are "very, very close" to government approval for this deal. The partnership, announced in December 2024, could add 20-22 million smartphone units annually to Dixon's capacity. The company is also expanding into other profitable areas. A display module assembly unit, in partnership with HKC Corp, is expected to start trials in Q3 FY27 and full production in Q4 FY27, with target revenues of ₹5,500-6,000 crore. Dixon plans to grow its IT hardware business to over ₹4,000 crore by FY27, including new facilities and SSD production. It is also exploring specialty electronic manufacturing services (EMS) in sectors such as aerospace, defense, medical, and industrial, aiming for ₹3,000-4,000 crore in revenue. Exports are increasing, with the iSmartu subsidiary set to ship feature phones and smartphones to Africa by Q2 FY27.

Valuation and Earnings Outlook

Nuvama has kept its target Price-to-Earnings (P/E) multiple at 55x for March 2027. Dixon Technologies currently trades at a P/E of around 37-40x, significantly below its 10-year average of 90.99x. Its valuation is also lower than competitors like Amber Enterprises India (over 188x P/E) and Syrma SGS Technology (53-75x P/E). Despite this, Nuvama's EPS cuts for FY27 highlight concerns. Emkay Global also lowered its FY27/28 EPS forecasts by 27-29%, anticipating fewer smartphone units and reduced benefits from the Production Linked Incentive (PLI) scheme. Dixon's Q4 FY26 net profit fell 36% year-on-year, even with steady revenue, as EBITDA margins dropped to 3.9%.

Strong Financial Health

Dixon Technologies boasts strong finances, according to Nuvama. The company manages its inventory and receivables efficiently, leading to negative working capital days. As of March 2025, its debt-to-equity ratio was a low 0.07, with total debt at ₹13.9 billion and shareholder equity at ₹46.8 billion, meaning it is almost debt-free. It holds substantial cash and short-term investments, totaling ₹6.4 billion, with a net cash position of ₹230 crore. This financial strength allows Dixon to invest in expanding capacity and manage market dips. Its Return on Equity (ROE) is between 28-37%, and Return on Capital Employed (ROCE) is about 42-45%.

Near-Term Risks: Margins and Demand

Near-term caution stems from several issues for Dixon Technologies. Rising component costs, especially for memory and DRAM, are squeezing smartphone manufacturing profit margins. The winding down of mobile Production Linked Incentive (PLI) benefits will also affect earnings, possibly reducing EBITDA margins by 50-70 basis points. Nuvama reported that smartphone volumes missed expectations last quarter, and the company expects flat growth in FY27 without the Vivo deal. The electronics manufacturing services (EMS) sector is highly competitive. Rivals like Amber Enterprises and Syrma SGS Technology trade at much higher P/E multiples, possibly reflecting market confidence in their growth prospects. Goldman Sachs rates Dixon a 'Sell', citing weaker performance and a cautious mobile outlook due to high DRAM prices. While government support for domestic manufacturing continues, potential changes in incentive policies present ongoing risks.

Investor Focus and Future View

Investors are keenly awaiting government approval for the Vivo JV, expected soon, which could significantly impact Dixon's FY27 volumes. The company's move into IT hardware, display modules, and specialty EMS is a strategic diversification aimed at higher-value market segments. India's push for domestic electronics production, targeting $300 billion by 2026, creates a positive economic environment, supported by programs like the PLI scheme. Analyst opinions are varied but generally positive, with 'Buy' ratings and target prices from ₹11,200 (JM Financial) to ₹14,600 (Motilal Oswal). However, weak consumer demand and ongoing margin pressures may limit short-term earnings growth. Successful execution of its diversification plans and navigating regulatory approvals will be key for Dixon Technologies to achieve its long-term goals.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.